MEIS1-AS3: A Potential Drug Target and Biomarker (G730198)

Target Name: MEIS1-AS3

NCBI ID: G730198

MEIS1-AS3

Other Name(s): MEIS1 antisense RNA 3

MEIS1-AS3: A Potential Drug Target and Biomarker

MeiS1 (Mesothelin-1) is a transmembrane glycoprotein that is highly expressed in various tissues, including the placenta, breast tissue, and human epidermis. It is known to play a critical role in cell-cell adhesion and has been implicated in various diseases, including cancer, obesity, and neurodegenerative disorders. The identification of potential drug targets and biomarkers for MEIS1 has the potential to lead to new therapeutic approaches for these diseases.

One potential drug target for MEIS1 is the RNA molecule known as AS3. AS3 is a non-coding RNA molecule that has been shown to interact with MEIS1 and can modulate its localization and stability. Several studies have demonstrated that AS3 can inhibit the activity of MEIS1 and can also enhance its stability. These findings suggest that AS3 may be a potential drug target for MEIS1-related diseases.

In addition to its potential as a drug target, AS3 has also been identified as a potential biomarker for several diseases, including cancer. Several studies have shown that AS3 levels are elevated in various types of cancer, including breast, ovarian, and prostate cancer. These findings suggest that AS3 may be a useful biomarker for monitoring the effectiveness of cancer treatments and for identifying potential drug targets for these diseases.

The potential drug target for AS3 is still in its early stages of research, but it is an exciting area of study that has the potential to lead to new therapeutic approaches for a variety of diseases. Further research is needed to fully understand the mechanisms of AS3 and its potential as a drug target and biomarker.

In conclusion, MEIS1-AS3 is a promising candidate for drug targeting and biomarker development. Further research is needed to fully understand its potential and to develop new therapeutic approaches for diseases associated with this molecule.

Protein Name: MEIS1 Antisense RNA 3

The "MEIS1-AS3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MEIS1-AS3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets